Publications by authors named "Wout A P Breeman"

Claim this Profile
T
Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount.
Mark W Konijnenberg, Wout A P Breeman, Erik de Blois, Ho Sze Chan, Otto C Boerman

EJNMMI Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo enzyme inhibition improves the targeting of [177Lu]DOTA-GRP(13-27) in GRPR-positive tumors in mice.
Panteleimon J Marsouvanidis, Marleen Melis, Erik de Blois, Wout A P Breeman, Eric P Krenning

Cancer Biother Radiopharm· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607.
Meltem Ocak, Anna Helbok, Christine Rangger, Petra Kolenc Peitl, Berthold A Nock, Wout A P Breeman

Eur J Nucl Med Mol Imaging· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues.
Rogier P J Schroeder, Cristina Müller, Suzanne Reneman, Marleen L Melis, Wout A P Breeman

Eur J Nucl Med Mol Imaging· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen-regulated gastrin-releasing peptide receptor expression in androgen-dependent human prostate tumor xenografts.
Rogier P J Schroeder, Monique de Visser, Wytske M van Weerden, Corrina M A de Ridder, Suzanne Reneman, Wout A P Breeman

Int J Cancer· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.
Alida C Fröberg, Marion de Jong, Berthold A Nock, Wout A P Breeman, Jack L Erion

Eur J Nucl Med Mol Imaging· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor imaging and therapy using radiolabeled somatostatin analogues.
Marion de Jong, Wout A P Breeman, Dik J Kwekkeboom, Roelf Valkema, Eric P Krenning

Acc Chem Res· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate.
Theodosia Maina, Berthold A Nock, Paul Cordopatis, Bert F Bernard, Wout A P Breeman

Eur J Nucl Med Mol Imaging· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer activity of targeted proapoptotic peptides.
Astrid Capello, Eric P Krenning, Bert F Bernard, Wout A P Breeman, Jack L Erion

J Nucl Med· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs.
Marion de Jong, Wout A P Breeman, Roelf Valkema, Bert F Bernard, Eric P Krenning

J Nucl Med· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased cell death after therapy with an Arg-Gly-Asp-linked somatostatin analog.
Astrid Capello, Eric P Krenning, Bert F Bernard, Wout A P Breeman, Martin P van Hagen

J Nucl Med· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyr3-octreotide and Tyr3-octreotate radiolabeled with 177Lu or 90Y: peptide receptor radionuclide therapy results in vitro.
Astrid Capello, Eric P Krenning, Wout A P Breeman, Bert F Bernard, Mark W Konijnenberg

Cancer Biother Radiopharm· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
Leo J Hofland, Steven W J Lamberts, P Martin van Hagen, Jean-Claude Reubi, James Schaeffer, Wout A P Breeman

J Nucl Med· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide receptor radionuclide therapy in vitro using [111In-DTPA0]octreotide.
Astrid Capello, Eric P Krenning, Wout A P Breeman, Bert F Bernard, Marion de Jong

J Nucl Med· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience.
Roelf Valkema, Marion De Jong, Willem H Bakker, Wout A p Breeman, Peter P m Kooij

Semin Nucl Med· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.
Marion De Jong, Roelf Valkema, Francois Jamar, Larry K Kvols, Dik J Kwekkeboom, Wout A P Breeman

Semin Nucl Med· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis